Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seltorexant adjunctive dose-finding study in adults with major depressive disorder and inadequate antidepressant response
2015-005282-22Phase 2Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of seltorexant in major depressive disorder (MDD), sponsored by Janssen Pharmaceutical. Started Jul 2017; status: completed.
02
Drugs
seltorexant
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on 2015-005282-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005282-22.